MedTrace Logo

Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer

NCT01215058 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2010-10-22

No results posted yet for this study

Summary

The purpose of this study is to assess gastroprotective agent compliance in patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer with NSAID.

Conditions

  • Gastrointestinal Hemorrhage
  • Ulcer

Sponsors & Collaborators

Principal Investigators

  • Jean-Francois Bretagne · Service gastro-enterologie et hepatologieCHRU Pontchaillou35033 RENNES cedex France

  • Gerard Thiefin · Service Hepato-Gastroenterologie CHU Reims51092 REIMS cedex France

  • Genevieve BONNELYE · KantarHealth - France138, avenue Marx Dormoy92120 Montrouge cedex

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-04-30
Completion
2011-04-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01215058 on ClinicalTrials.gov